contract_awardAwarded Monday, July 20, 2026Analyzed

NEW HAMPSHIRE DEPARTMENT OF HEALTH & HUMAN SERVICES: $90.8M Department of Health and Human Services Grant

Neutral

Summary

This $90.8M grant to the New Hampshire Department of Health & Human Services for opioid response does not directly benefit any publicly traded company. The contract supports public health initiatives in substance use disorder treatment and prevention, with no clear impact on corporate earnings.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.The recipient is a state government agency, not a publicly traded company, so no direct corporate beneficiary exists.
  • 2.The $90.8M grant spans three years and supports opioid treatment and prevention services in New Hampshire.
  • 3.No related bills in the database share a specific funding or policy objective with this award, limiting legislative tailwinds.

Market Implications

This contract has no identifiable market implications for publicly traded equities. The grant is administered by a state agency and does not create revenue streams for specific corporations. Investors focused on the opioid treatment space may monitor broader federal funding trends, but this particular award lacks a clear public-company nexus.

Full Analysis

The Substance Abuse and Mental Health Services Administration awarded a $90.8M project grant to the New Hampshire Department of Health & Human Services for the State Opioid Response (SOR) 2024 program. The grant funds a comprehensive continuum of care for opioid and stimulant use disorders, targeting special populations across the state. As the recipient is a state government entity, no publicly traded company receives direct revenue from this award. The contract reflects ongoing federal investment in combating the opioid crisis but does not flow to private-sector beneficiaries in a traceable manner. Related legislation in the dataset, such as the Work Without Worry Act of 2026 (S5006), touches on healthcare workforce but lacks a direct funding mechanism or objective alignment with this specific grant. Therefore, retail investors should not expect material stock movements from this contract award.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationJul 13, 2026

Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security

President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).

Exec OrderJun 25, 2026

Advancing Regenerative Agriculture and Strengthening American Farm Resilience

This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.

Exec OrderJun 3, 2026

Implementing Schedule Policy/Career in the Excepted Service

This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.

Contract Details

Recipient

NEW HAMPSHIRE DEPARTMENT OF HEALTH & HUMAN SERVICES

Award Amount

$90,828,983

Awarding Agency

Department of Health and Human Services

Sub-Agency

Substance Abuse and Mental Health Services Administration

Contract Type

PROJECT GRANT (B)

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →